当前位置:首页 - 行情中心 - 圣达生物(603079) - 财务分析 - 现金流量表

圣达生物

(603079)

  

流通市值:30.60亿  总市值:30.60亿
流通股本:1.89亿   总股本:1.89亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金220,208,923.66846,046,400.65639,336,489.2410,427,102.53
  收到的税费返还6,264,366.9440,609,928.7220,142,986.2516,623,182.86
  收到其他与经营活动有关的现金10,762,471.5716,791,902.4618,473,388.236,932,080.24
  经营活动现金流入小计237,235,762.17903,448,231.83677,952,863.68433,982,365.63
  购买商品、接受劳务支付的现金164,585,692.05532,280,904.15437,142,455.42291,722,566.74
  支付给职工以及为职工支付的现金49,627,540.74140,113,315.43107,553,375.6477,205,480.47
  支付的各项税费16,791,816.2350,074,800.6834,154,476.8425,411,932.07
  支付其他与经营活动有关的现金9,454,338.3142,094,659.6931,437,678.0716,677,920.4
  经营活动现金流出小计240,459,387.33764,563,679.95610,287,985.97411,017,899.68
  经营活动产生的现金流量净额-3,223,625.16138,884,551.8867,664,877.7122,964,465.95
二、投资活动产生的现金流量:
  收回投资收到的现金450,812,3001,372,286,3751,042,286,375569,286,375
  取得投资收益收到的现金947,387.442,064,913.511,325,624.94754,511.08
  处置固定资产、无形资产和其他长期资产收回的现金净额20,6701,133,886.97224,025.99116,537.9
  投资活动现金流入小计451,780,357.441,375,485,175.481,043,836,025.93570,157,423.98
  购建固定资产、无形资产和其他长期资产支付的现金36,214,237.31145,682,849.07107,304,649.5971,157,258.21
  投资支付的现金290,000,0001,547,008,315.291,047,008,315.29581,211,235
  投资活动现金流出小计326,214,237.311,692,691,164.361,154,312,964.88652,368,493.21
  投资活动产生的现金流量净额125,566,120.13-317,205,988.88-110,476,938.95-82,211,069.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金-266,879,190264,529,990264,529,990
  取得借款收到的现金13,000,000141,500,000123,500,000100,000,000
  筹资活动现金流入小计13,000,000408,379,190388,029,990364,529,990
  偿还债务支付的现金2,000,00079,000,00079,000,00077,000,000
  分配股利、利润或偿付利息支付的现金2,035,638.647,813,279.85,647,274.673,745,235.28
  支付其他与筹资活动有关的现金471,842.082,496,052.922,089,389.411,746,081.22
  筹资活动现金流出小计4,507,480.7289,309,332.7286,736,664.0882,491,316.5
  筹资活动产生的现金流量净额8,492,519.28319,069,857.28301,293,325.92282,038,673.5
四、汇率变动对现金及现金等价物的影响-3,083,736.08-1,487,249.359,278712,737.18
五、现金及现金等价物净增加额127,751,278.17139,261,170.93258,490,542.68223,504,807.4
  加:期初现金及现金等价物余额402,769,768.25263,508,597.32263,508,597.32263,508,597.32
  期末现金及现金等价物余额530,521,046.42402,769,768.25521,999,140487,013,404.72
补充资料:
  净利润-69,264,339.67-40,495,558.21
  资产减值准备-10,153,834.42-933,206.09
  固定资产和投资性房地产折旧-68,918,855.7-32,184,710.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,918,855.7-32,184,710.46
  无形资产摊销-7,533,701.17-3,748,760.61
  长期待摊费用摊销-4,924,416.25-2,416,063.61
  处置固定资产、无形资产和其他长期资产的损失-477,311.75-86,177.7
  固定资产报废损失-381,244.7--
  公允价值变动损失--49,263.4-958.36
  财务费用-2,425,956.35--285,413.35
  投资损失--2,064,913.51--754,511.08
  递延所得税--6,222,855.73--497,393.87
  其中:递延所得税资产减少--6,941,924.36--421,952.67
    递延所得税负债增加-719,068.63--75,441.2
  存货的减少--2,887,112.73--46,728,453.48
  经营性应收项目的减少--24,848,938.01-333,533,988.29
  经营性应付项目的增加-9,150,535.65--342,480,464.37
  其他-138,180--
  现金的期末余额-402,769,768.25-487,013,404.72
  减:现金的期初余额-263,508,597.32-263,508,597.32
  现金及现金等价物的净增加额-139,261,170.93-223,504,807.4
公告日期2026-04-272026-04-272025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑